CytoDyn’s leronlimab reduces mortality by 82% at 14 days in critically ill COVID-19 patients
30 March 2021 - 10:08PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Apr 2024 to May 2024
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From May 2023 to May 2024